CAS: 1951431-22-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
BKI-1369 REF: 3D-BDD43122CAS: 1951431-22-3 | Min. 95% | A consultar | Jue 11 Jul 24 | |
BKI-1369 REF: TM-T10556CAS: 1951431-22-3 | - - - | 158,00 €~2.340,00 € | Jue 18 Jul 24 |
BKI-1369
CAS:1951431-22-3
BKI-1369 is an experimental drug in the class of benzimidazole derivatives that is being studied …
Fórmula:
C23H27N7O
Pureza:
Min. 95%
Peso molecular:
417.51 g/mol
Ref: 3D-BDD43122
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 11 de Julio de 2024
BKI-1369
CAS:1951431-22-3
BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM).
Fórmula:
C23H27N7O
Peso molecular:
417.51
Ref: TM-T10556
5mg | 444,00 € | |
25mg | 1.410,00 € | |
50mg | 1.854,00 € | |
100mg | 2.340,00 € |
Entrega estimada en Estados Unidos, el Jueves 18 de Julio de 2024